PRESS RELEASE published on 12/28/2023 at 14:10, 2 years 1 month ago NeoGenomics to Appeal Ruling NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 2 months ago NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE published on 11/14/2023 at 13:00, 2 years 3 months ago NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE published on 11/06/2023 at 22:05, 2 years 3 months ago NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE published on 10/24/2023 at 13:00, 2 years 3 months ago NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE published on 10/17/2023 at 15:20, 2 years 4 months ago NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Published on 02/20/2026 at 15:45, 1 hour 25 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 2 hours 40 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 3 hours 2 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 3 hours 10 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 13:30, 3 hours 40 minutes ago ESGold Launches 70 km2 District-Scale ANT Survey at Montauban Following 3D Model Identifying Deep, Expanding 2 km Mineralized Corridor
Published on 02/20/2026 at 17:05, 5 minutes ago Eurobattery Minerals publishes its year-end report for 2025 while working on design & construction of the tungsten processing plant at San Juan
Published on 02/20/2026 at 15:24, 1 hour 46 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 02/20/2026 at 15:23, 1 hour 47 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 02/20/2026 at 09:28, 7 hours 42 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 7 hours 42 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 9 hours 40 minutes ago Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan
Published on 02/20/2026 at 07:30, 9 hours 40 minutes ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 9 hours 40 minutes ago Announcement of share buyback in the context of a share purchase plan